The report described 14 pregnancies in 13 patients who had received CAR T-cell therapy for autoimmune disease.
2
No autoimmune disease flares occurred during pregnancy, and all but one patient remained drug-free or used only prophylactic hydroxychloroquine.
3
Eight healthy babies had been born, five pregnancies were ongoing, and one pregnancy was electively terminated for reasons unrelated to autoimmune disease.
4
Newborns had no detectable CAR T cells, and reported CD19-positive B-cell counts, immunoglobulin G levels, and early development were normal.
5
The researchers called for pregnancy registries and further studies of fertility after lymphodepletion and CAR T-cell treatment.